Gapping down
In reaction to disappointing earnings/guidance: RAD -12.7%, CPRT -8.5%.
Select financial related names showing weakness: IRE -4.3%, AIB -3.6%, CS -3.0%, STD -2.9%, MFC -2.6%, ING -2.4%, LYG -2.3%, HBAN -2.1%, RDN -2.1%, MET -1.9%, IBN -1.7%, DB -1.7%, AIG -1.6%, RF -1.6%, HIG -1.4%.
Select metals/mining stocks trading lower: MT -2.3%, CLF -2.0%, RTP -1.8%, BBL -1.7%, GFI -1.5%, SWC -1.4%, AA -1.3%, BHP -1.2%, FCX -1.1%, GSS -1.0%.
Select oil/gas related names showing weakness: PTEN -3.1%, TOT -1.7%, E -1.7%, MMR -1.6%, BEXP -1.5%, RIG -1.3%, SU -1.1%, RDS.A -1.1%.
Other news: NOVL -7.8% (under pressure on reports out overnight speculating Linux sale), TIVO -6.5% (still checking for anything specific), QGEN -3.8% (still checking; German manufacturing data was out overnight), VRSK -3.8% (announces stockholders are offering 19 mln shares in a secondary public offering), VRTX -3.2% (prices public offering of $375 mln convertible senior subordinated notes), FRO -3.1% (still checking), OFG -3.0% (files for 13.32 mln share common stock offering by selling securityholders), WPZ -2.9% (announces 8.25 mln common units public offering), O -2.5% (announces commencement of 3.7 mln share public offering of common stock), AZPN -2.4% (weakness attributed to pricing of offering).
Analyst comments: CVVT -8.2% (downgraded to Neutral from Overweight at Piper Jaffray), CGV -6.3% (downgraded to Neutral from Overweight at JP Morgan), OXPS -4.5% (downgraded to Sell from Neutral at Goldman), TIF -4.1% (downgraded to Sell from Neutral at Goldman), DYN -2.8% (downgraded to Neutral from Overweight at JP Morgan), AZN -1.7% (downgraded to Underperform from Neutral at Exane), MO -1.3% (Hearing downgraded to Hold from Buy at Stifel Nicolaus).
Gapping up
In reaction to strong earnings/guidance: RHT +5.3%, BBBY +4.4%, SCHL +3.9% (also announces intent to commence modified Dutch auction to repurchase $150 mln of common stock), DIN +2.8% (sees FY10 Applebee's domestic comps flat to -3%; IHOP comps -1 to +1% ), SCS +1.8% (light volume).
M&A news: TESS +18.3% (Discovery Equity Partners files amended 13D; proposes acquiring shares not currently owned at a price of $15.50 per share), BXC +14.7% (Cerberus to increase in tender offer price to $4.00 and extends cash tender offer for the outstanding shares in BXC not owned by its affiliate), CADE +6.7% (Trustmark Corporation and Cadence Financial announce definitive merger agreement).
Other news: EW +11.4% (receives approval to begin U.S. clinical trial of next-generation transcatheter valve; upgraded to Overweight from Neutral at Piper Jaffray), BNVI +9.8% (trading under BNVID; announces FDA approves manufacturing plan for Menerba), ZIOP +9.3% (receives FDA orphan drug designation for darinaparsin in the treatment of peripheral t-cell lymphoma), CDII +8.9% (receives additional contract for its basic materials segment valued at over $30 million ), WG +5.7% (still checking), SCHL +3.9% (announces intent to commence modified Dutch auction to repurchase $150 mln of common stock), UHT +1.3% (will replace Baldor Electric in the S&P SmallCap 600 index).
Analyst comments: AKAM +1.5% (ests and target raised to $58 at Oppenheimer following checks; Cramer makes positive comments), NVDA +1.2% (upgraded to Outperform from Market Perform at BMO Capital).